Elena Salobrar-García is an expert in Ophthalmology at Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (Spain). Elena Salobrar-García has authored 111 publications, the most recent in 2026. SLR score: 262 (community average: 125). How the SLR is computed.

LeadR Profile

262 ScienceLeadR Reputation 262
Network Map

Ophthalmology

Subspecialties: Neurology - Biochemistry - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2015 - 2026

Source: PubMed

Complutense University of Madrid

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 111

Citations

Citations: 1 567 1st author: 17 Last author: 4 Unique author: 6


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Neuroprotective and Anti-Inflammatory Effects of SOCS1 Mimetic Peptides in Mouse Diabetic Retinopathy.
PMID 42872951 — cells, ophthalmology, therapeutics, retinaldehyde, diabetic retinopathy
Invest Ophthalmol Vis Sci20260
Spontaneous Achromatopsia-Like Phenotype in Albino Swiss CD-1 Mice: Retinocortical Dysfunction, Neurovascular Remodeling, and Glial Activation.
PMID 42853007 — cells, vision, ocular, ophthalmology, tomography, phenotype, tomography, optical coherence, research, ganglion cysts, retinaldehyde
Invest Ophthalmol Vis Sci20260
Tears as a window to Alzheimer's disease: A systematic review of biomarkers for early detection.
PMID 41767157 — extracellular vesicles, tears, alzheimer disease, micrornas, biomarkers, diagnosis
Alzheimers Dement (Amst)20260
In Vivo Functional and Structural Retinal Preservation by Combined Administration of Citicoline and Coenzyme Q10 in a Murine Model of Ocular Hypertension.
PMID 41596656 — eye, coenzymes, hypertension, neuroprotection, lasers, ocular hypertension, therapeutics, retinaldehyde, cytidine diphosphate choline
Int J Mol Sci20260
Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension.
PMID 40430513 — microglia, coenzymes, cells, hypertension, astrocytes, retina, neuroglia, lasers, glaucoma, ocular hypertension, therapeutics, visual pathways, pharmaceutical vehicles, cytidine diphosphate choline
Pharmaceuticals (Basel)20250

LeadR Networks

Main global connection map